Mutations of the D310 mitochondrial mononucleotide repeat in primary tumors and cytological specimens

Cancer Letters

Volumn 190, Issue 1, 2003, Pages 73-77

  Parrella, Paola ^a,b   Seripa, Davide ^a   Matera, Maria Giovanna ^a   Rabitti, Carla ^c   Rinaldi, Monica ^d   Mazzarelli, Paola ^c,d   Gravina, Carolina ^a   Gallucci, Michele ^c,e   Altomare, Vincenzo ^c,e   Flammia, Gerardo ^c,e   Casalino, Beniamino ^c   Benedetti Panici, Pier Luigi ^c   Fazio, Vito M ^a,c  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d CNR   (Italy)

^e H 'Cristo Re'   (Italy)

Author keywords

Breast cancer; Cervical carcinoma; D310; Diagnosis; Mitochondrial genome; Mutation; Transitional cell carcinoma

Indexed keywords

MITOCHONDRIAL DNA;

ARTICLE; BLADDER TUMOR; BREAST CANCER; CANCER DIAGNOSIS; CYTOLOGY; ENDOMETRIUM CANCER; GENE DELETION; GENE INSERTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MUTATION; MUTATION RATE; NEEDLE BIOPSY; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; TUMOR; UTERINE CERVIX CANCER;

INSERTION SEQUENCES;

EID: 0037428857     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00578-5     Document Type: Article

References (23)

1. Sidransky D. Nucleic acid based method for detection of cancer. Science. 278:1997;1054-1059.
2. Ahrendt S.A., Chow J., Xu L.H., Yang S.C., Eisenberg C.F., Esteller M., Herman J.G., Wu L., Decker P.A., Jen J., Sidransky D. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J. Natl. Cancer Inst. 17:1999;332-339.
3. Dong S.M., Traverso G., Johnson C., Geng L., Favis R., Boyton K., Hibi K., Goodman S.N., D'Allessio M., Paty P., Hamilton S.R., Sidransky D., Barany F., Levin B., Shuber A., Kinzler K.W., Vogelstein B., Jen J. Detecting colorectal cancer in stool with the use of multiple genetic targets. J. Natl. Cancer Inst. 93:2001;858-865.
4. Mao L., Schoenberg M.P., Scicchitano J.F.M., Erozan Y.S., Merlo A., Schwab D., Sidransky D. Molecular detection of primary bladder cancer by microsatellite analysis. Science. 271:1996;659-662.
5. Steiner G., Schoenberg M.P., Linn J.F., Mao L., Sidransky D. Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat. Med. 3:1997;621-624.
6. Seripa D., Parrella P., Gallucci M., Gravina C., Papa S., Fortunato P., Alcini A., Flammia G., Lazzari M., Fazio V.M. Sensitive detection of transitional cell carcinoma of the bladder by microsatellite analysis of cells exfoliated in urine. Int. J. Cancer. 93:2001;364-369.
7. Rha S.H., Dong S.M., Jen J., Nicol T., Sidransky D. Molecular detection of cervical intraepithelial neoplasia and cervical carcinoma by microsatellite analysis of Papanicolaou smears. Int. J. Cancer. 93:2001;424-429.
8. Polyak K., Li Y., Zhu H., Lengauer C., Willson J.K., Markowitz S.D., Trush M.A., Kinzler K.W., Vogelstein B. Somatic mutations of the mitochondrial genome in human colorectal tumors. Nat. Genet. 20:1998;291-293.
9. Fliss M.S., Usadel H., O L., Caballero L., Wu M.R., Buta S.M., Eleff J., Jen D. Facile detection of mitochondrial DNA mutations in tumors and bodily fluid. Science. 287:2000;2017-2019.
10. Jones J.J., Song J.J., Hempen P.M., Parmigiani G., Hruban R.H., Kern S.E. Detection of mitochondrial DNA mutations in pancreatic cancer offer a 'mass'-ive advantage over detection of nuclear DNA mutations. Cancer Res. 61:2001;1299-1304.
11. Liu V.W.S., Shi H.H., Cheung A.N.Y., Chiu P., Leung T.W., Nagley P., Wong L.C., Ngan H.Y.S. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res. 61:2001;5998-6001.
12. Parrella P., Xiao Y., Fliss M., Sanchez-Cespedes M., Mazzarelli P., Rinaldi M., Nicol T., Gabrielson E., Cuomo C., Cohen D., Pandit S., Spencer M., Rabitti C., Fazio V.M., Sidransky D. Detection of mitochondrial DNA mutations in primary breast cancer and fine needle aspirates. Cancer Res. 61:2001;7623-7626.
13. Sanchez-Cespedes M., Parrella P., Nomoto S., Cohen D., Xiao Y., Esteller M., Jeronimo C., Jordan R.C.K., Nicol T., Koch W.M., Schoenberg M., Mazzarelli P., Fazio V., Sidransky D. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res. 61:2001;7015-7019.
14. Parrella P., Sidransky D., Merbs S.L. Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway. Cancer Res. 59:1999;3032-3037.
15. Litt M., Hauge X., Sharma V. Shadows bands seen when typing polymorphic dinucleotide repeats: some causes and cures. Biotechniques. 15:1993;280-284.
16. Coller H.A., Khrapko K., Bodyak N.D., Nekhaeva E., Herrero-Jimenez P., Thilly W.G. High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat. Genet. 28:2001;147-150.
17. Parsons T.J., Muniec D.S., Sullivan K., Woodyatt N., Alliston-Greiner R., Wilson M.R., Berry D.L., Holland K.A., Weedn V.W., Gill P., Holland M.M. A high observed substitution rate in the human mitochondrial DNA control region. Nat. Genet. 15:1997;363-368.
18. Tully L.A., Parsons T.J., Steighner R.J., Holland M.M., Marino M.A., Prenger V.L. A sensitive denaturing gradient gel electrophoresis assay reveals a high frequency of heteroplasmicity in hypervariable region 1 of the human mitochondrial DNA control region. Am. J. Hum. Genet. 67:2000;432-443.
19. Backer J.M., Weinstein I.B. Mitochondrial DNA is a major cellular target for a dihydrodiol-epoxide derivative of benzo[a]pyrene. Science. 209:1980;297-299.
20. Allen J.A., Combs M.M. Covalent binding of polycyclic aromatic compounds to mitochondrial and nuclear DNA. Nature. 287:1980;244-245.
21. Kunkel T.A., Loeb L.A. Fidelity of mammalian DNA polymerases. Science. 213:1981;765-767.
22. Oberley L.W., Buettner G.R. Role of superoxide dismutase in cancer: a review. Cancer Res. 39:1979;1141-1149.
23. Ha P.K., Tong B.C., Westra W.H., Sanchez-Cespedes M., Parrella P., Zahurack M., Sidransky D., Califano J.A. Mitochondrial C-tract alterations in premalignant lesions of the head and neck: a marker for progression and clonal proliferation. Clin. Cancer Res. 8:2002;2260-2265.